תוצאות חיפוש - Laurence Lawrence‐Archer
- Showing 1 - 2 results of 2
-
1
Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease מאת Mona Synnøve Bjune, Laurence Lawrence‐Archer, Johnny Laupsa‐Borge, Cathrine Horn Sommersten, Adrian McCann, Robert C. Glastad, Iain G. Johnston, Matthias Kern, Matthias Blüher, Gunnar Mellgren, Simon N. Dankel
יצא לאור 2023Artigo -
2
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab מאת Cindy X. Cai, Akihiko Nishimura, Mary G. Bowring, Erik Westlund, Diep Tran, Jia Hwei Ng, Paul Nagy, Michael B. Cook, Jody‐Ann McLeggon, Scott L. DuVall, Michael E. Matheny, Asieh Golozar, Anna Ostropolets, Evan Minty, Priya Desai, Fan Bu, Brian C. Toy, Michelle R. Hribar, Thomas Falconer, Linying Zhang, Laurence Lawrence‐Archer, Michael V. Boland, Kerry Goetz, Nathan Hall, Azza Shoaibi, Jenna Reps, Anthony G. Sena, Clair Blacketer, Joel N. Swerdel, Kenar D. Jhaveri, Edward Lee, Zachary Gilbert, Scott L. Zeger, Deidra C. Crews, Marc A. Suchard, George Hripcsak, Patrick Ryan
יצא לאור 2024Artigo
כלי חיפוש:
נושאים קשורים
Internal medicine
Medicine
Aflibercept
Amino acid
Apoptosis
Bevacizumab
Biochemistry
Biology
Chemotherapy
Cohort
Confidence interval
Cumulative incidence
Disease
Downregulation and upregulation
Endocrinology
Fatty liver
Gene
Gene knockdown
Hazard ratio
Incidence (geometry)
Ophthalmology
Optics
PDK4
Physics
Ranibizumab
Surgery
Valine